EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of ACE2 in Neurological Disorders: From Underlying Mechanisms to the Neurological Impact of COVID-19

Jingwen Li, Xiangrui Kong, Tingting Liu iD, Meiyan Xian, Jianshe Wei iD

International Journal of Molecular Sciences · 15.09.2024 · 25 (18) · 9960

DOI: 10.3390/ijms25189960 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.09.2024. Verfasst von Jingwen Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Brain Sciences Research, School of Life Sciences, Henan University, Kaifeng 475004, China. Hauptthemen laut MEDLINE: COVID-19, Angiotensin-Converting Enzyme 2, Nervous System Diseases, SARS-CoV-2. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Henan Province Natural Science Foundation of China, Bio-Med Interdisciplinary Innovative Program of Henan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiotensin-converting enzyme 2 (ACE2) has become a hot topic in neuroscience research in recent years, especially in the context of the global COVID-19 pandemic, where its role in neurological diseases has received widespread attention. ACE2, as a multifunctional metalloprotease, not only plays a critical role in the cardiovascular system but also plays an important role in the protection, development, and inflammation regulation of the nervous system. The COVID-19 pandemic further highlights the importance of ACE2 in the nervous system. SARS-CoV-2 enters host cells by binding to ACE2, which may directly or indirectly affect the nervous system, leading to a range of neurological symptoms. This review aims to explore the function of ACE2 in the nervous system as well as its potential impact and therapeutic potential in various neurological diseases, providing a new perspective for the treatment of neurological disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Angiotensin-Converting Enzyme 2Nervous System DiseasesSARS-CoV-2HumansAnimals

Stichwörter der Autor:innen

ACE2COVID-19neurodegenerative diseasesneurological disordersneuroprotection

Substanzen

Angiotensin-Converting Enzyme 2ACE2 protein, human

Autor:innen und Institutionen

  • Institute for Brain Sciences Research, School of Life Sciences, Henan University, Kaifeng 475004, China.
  • Institute for Sports and Brain Health, School of Physical Education, Henan University, Kaifeng 475004, China.

ORCID-Profile: Tingting Liu, Jianshe Wei

Förderung

  • National Natural Science Foundation of China
  • Henan Province Natural Science Foundation of China
  • Bio-Med Interdisciplinary Innovative Program of Henan University

Zitieren

APA

Li, J., Kong, X., Liu, T., Xian, M., & Wei, J. (2024). The Role of ACE2 in Neurological Disorders: From Underlying Mechanisms to the Neurological Impact of COVID-19. International Journal of Molecular Sciences, 25(18), 9960. https://doi.org/10.3390/ijms25189960

Vancouver

Li J, Kong X, Liu T, Xian M, Wei J. The Role of ACE2 in Neurological Disorders: From Underlying Mechanisms to the Neurological Impact of COVID-19. International Journal of Molecular Sciences. 2024;25(18):9960. doi:10.3390/ijms25189960

BibTeX
@article{Li2024,
  author = {Li, Jingwen and Kong, Xiangrui and Liu, Tingting and Xian, Meiyan and Wei, Jianshe},
  title = {The Role of ACE2 in Neurological Disorders: From Underlying Mechanisms to the Neurological Impact of COVID-19},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {18},
  pages = {9960},
  doi = {10.3390/ijms25189960}
}
Kostenlos starten →